GLP-1 Agonists: A New Hope for Parkinson’s Disease
Reading Time: 3 minutes
Introduction
The discovery of GLP-1 receptor agonists as potential treatments for Parkinson’s disease (PD) opens an exciting new chapter for the medical community and patients alike. GLP-1 receptor agonists, initially developed …
Read MoreCarbidopa-Levodopa Explained
Reading Time: 2 minutes
Parkinson’s disease is a progressive neurological disorder that affects movement, causing symptoms like tremors, stiffness, and slowed motion. A cornerstone in managing these motor symptoms is the combination medication Carbidopa-Levodopa. …
New Discovery: Ophthalmic Acid as a Potential Treatment for Parkinson’s Disease
Reading Time: 4 minutes
In a groundbreaking study, researchers from the University of California, Irvine, have identified ophthalmic acid (OA), a molecule once considered irrelevant to neurotransmission, as a key player in motor function …
Metformin and Psilocybin: New Hope for Parkinson’s
Reading Time: 3 minutes
Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects millions worldwide. Characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms like cognitive impairments …
Read MoreEssential Tremor vs Parkinson’s
Reading Time: 3 minutes
Understanding the differences between Essential Tremor (ET) and Parkinson’s Disease (PD) is crucial for accurate diagnosis and effective treatment. Both are neurological disorders that cause tremors, but they have distinct …